A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Unfractionated heparin (UFH) use during dialysis has a narrow therapeutic window; if misjudged the dose administered by nurses based on visual assessment of post dialysis clotting and hemostasis time can cause adverse bleeding or ill effects in these patients. The purpose of this MN thesis prospective study was to examine the efficacy of a new heparin protocol. Specific research questions included: 1) Will the use of a more aggressive heparin-reduction protocol reduce the cumulative heparindoi:10.11575/prism/26623 fatcat:bod3zjktlfdxzdvodlhxzwkpzi